Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...

Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

(PeopleImages/Getty Images) A common diabetes drug may hold great potential to help with aging, even if scientists aren't ...

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

Study results show high treatment discontinuation and low adherence among US adults with painful diabetic peripheral neuropathy.

Medications developed to control blood sugar are now at the center of a very different scientific story: how they might raise or lower the odds of developing cancer. As researchers follow millions of ...

New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer ...